AMIT PATEL: Open Payments
NPI 1316208093 · COLDWATER, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,733 in 135 payments from 23 companies in 2025. Trend: 2023 $3,867 · 2024 $4,443 · 2025 $2,733
Food & beverage: $2,733
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $373 |
| Novo Nordisk Inc | 9 | $263 |
| Abbott Laboratories | 6 | $257 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $254 |
| ABBVIE INC. | 20 | $211 |
| GlaxoSmithKline, LLC. | 13 | $207 |
| Ardelyx, Inc. | 11 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $165 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $123 |
| Electromed, Inc. | 5 | $120 |
Products named: Kerendia, TRELEGY ELLIPTA, IBSRELA, Ozempic, FARXIGA, AIRSUPRA, CAPLYTA, ETERNA.
Industry payments across MS — which companies pay providers there.
